Advertisement
Screener

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

KRAIG BIOCRAFT LABORATORIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-09-30 was 9.00M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-06-30 was 0.00 shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 0.00 shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 2.20M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 0.00 shares, a 100.00% decline from fiscal 2017.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 30.00M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was -27.50M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2021-12-312.20M shares
10-K · filed 2023-03-29
2019-09-309.00M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
9.00M shares
derived: sum of 4 quarters · filed 2019-11-13
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
0.00 shares
derived: sum of 4 quarters · filed 2019-08-12
2019-03-310.00 shares
10-Q · filed 2019-05-13
0.00 shares
derived: sum of 4 quarters · filed 2019-05-13
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
0.00 shares
10-K · filed 2019-03-29
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
15.00M shares
derived: sum of 4 quarters · filed 2018-11-13
2018-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
15.00M shares
derived: sum of 4 quarters · filed 2018-08-10
2018-03-310.00 shares
10-Q · filed 2018-05-11
29.25M shares
derived: sum of 4 quarters · filed 2018-05-11
2017-12-3115.00M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
30.00M shares
10-K · filed 2018-03-23
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15
11.00M shares
derived: sum of 4 quarters · filed 2017-11-15
2017-06-3014.25M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
11.00M shares
derived: sum of 4 quarters · filed 2017-08-14
2017-03-31750.00K shares
10-Q · filed 2017-05-12
-26.75M shares
derived: sum of 4 quarters · filed 2017-05-12
2016-12-31-4.00M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
-27.50M shares
10-K · filed 2017-03-22
2016-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-23.50M shares
derived: sum of 4 quarters · filed 2017-03-22
2016-06-30-23.50M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
-24.70M shares
derived: sum of 4 quarters · filed 2017-03-22
2016-03-310.00 shares
10-Q · filed 2016-05-13
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
-4.20M shares
10-K · filed 2017-03-22
2015-09-30-1.20M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
-10.00M shares
10-K · filed 2016-03-30
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23
-10.00M shares
derived: sum of 4 quarters · filed 2015-03-31
2014-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
2014-03-31-10.00M shares
10-Q · filed 2014-05-15
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
-10.00M shares
10-K · filed 2015-03-31
2013-03-310.00 shares
10-Q/A · filed 2013-12-24
0.00 shares
derived: sum of 4 quarters · filed 2014-04-15
2012-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-15
0.00 shares
10-K · filed 2014-04-15
2012-09-300.00 shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
0.00 shares
derived: sum of 4 quarters · filed 2013-12-24
2012-06-300.00 shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-10
0.00 shares
derived: sum of 4 quarters · filed 2013-12-24
2012-03-310.00 shares
10-Q/A · filed 2013-12-24
2.57M shares
derived: sum of 4 quarters · filed 2013-12-24
2011-12-310.00 shares
derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-12-24
2.57M shares
10-K/A · filed 2013-12-24
2011-09-300.00 shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19
2011-06-302.57M shares
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10
2011-03-310.00 shares
10-Q · filed 2012-05-21
2010-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14